Tag Archives: After

J&J, Bayer’s Xarelto scores FDA nod to treat acutely ill patients during and after hospitalization

Johnson & Johnson and Bayer’s Xarelto, once king of the warfarin alternative market, is now chasing chasing Pfizer and Bristol-Myers Squibb’s Eliquis. But with a new approved indication in the books—its eighth—it’s not backing down. The FDA on Monday approved Xarelto to help prevent blood clots for acutely ill patients without a high risk of bleeding during… Read More »

'Fussy eater' (17) left blind and deaf after diet of chips, sausages and crisps

A teenager has been left blind and partially deaf after living off a diet of chips, sausages and crisps. The British 17-year-old’s diet was so bad he suffered from a condition normally only seen in malnourished third-world children. Researchers from Bristol Eye Hospital have published a report into the boy’s case, which believed to be the first… Read More »